Tamar Peretz

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

Doron Lipson, Marzia Capelletti, Roman Yelensky et al. · Nature Medicine · 2012 · 869 citations

Medicine, Molecular Genetics, Oncology +16

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

Jeffery P. Struewing, Dvorah Abeliovich, Tamar Peretz et al. · Nature Genetics · 1995 · 658 citations

Life Sciences, Genetics, Molecular Genetics +10

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

Dvorah Abeliovich, Luna Kaduri, Israela Lerer et al. · PubMed · 1997 · 359 citations

Life Sciences, Genetics, Molecular Genetics +12

Determinants of the Use of Complementary Therapies by Patients With Cancer

Ora Paltiel, Malka Avitzour, Tamar Peretz et al. · Journal of Clinical Oncology · 2001 · 244 citations

Medicine, Oncology, Medical Oncology +9

Heparanase Gene Silencing, Tumor Invasiveness, Angiogenesis, and Metastasis

Evgeny Edovitsky, Michael Elkin, Eyal Zcharia et al. · JNCI Journal of the National Cancer Institute · 2004 · 238 citations · Full text

Medicine, Cancer Biology, Oncology +15